INHALE THERAPEUTIC SYSTEMS INC
S-3, EX-23.1, 2001-01-12
PHARMACEUTICAL PREPARATIONS
Previous: INHALE THERAPEUTIC SYSTEMS INC, S-3, EX-5.1, 2001-01-12
Next: INHALE THERAPEUTIC SYSTEMS INC, S-3, EX-23.2, 2001-01-12



<PAGE>
                                              EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

    We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Inhale Therapeutic
Systems, Inc. for the registration of 4,558,065 shares of its common stock and
$230,000,000 of its 3.5% Convertible Subordinated Notes due October 17, 2007,
and to the incorporation by reference therein of our report dated January 24,
2000, with respect to the financial statements of Inhale Therapeutic Systems,
Inc. included in its Annual Report (Form 10-K), as amended, for the year ended
December 31, 1999, filed with the Securities and Exchange Commission.

                                              /s/ Ernst & Young LLP

Palo Alto, California
January 12, 2001


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission